Hereditary Breast/Ovarian Cancer - BRCA2
1 clinical trials · Condition
◉ Watch Hereditary Breast/Ovarian Cancer - BRCA2
| Record | Firm | Date |
|---|---|---|
| Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer (NCT01104259) | University of Washington | 2010-07-01 |
Track Hereditary Breast/Ovarian Cancer - BRCA2 automatically
Every clearance here is in the API, with alerts when new ones post.